ADS-ADEA 2016* Clinical Science
Chairs: Jane Holmes-Walker & Sandra Neoh
A Comparison of Glycaemic Control in Adults and Adolescents With Type 1 Diabetes When Using a Closed Loop Insulin Delivery System Overnight Versus Sensor-Augmented Pump With Low Glucose Suspend At Home: A Randomised Crossover Study (#159)
9:00 AM
Overnight Glucose and Counter-regulatory Hormone Profiles in Type 1 Diabetes Adults during Closed Loop Insulin Delivery vs Sensor Augmented Pump with Low Glucose Suspend (#160)
9:15 AM
Comparison of service utilisation and outcomes in young adults aged 16-25 managed with multiple daily injections(MDI) and continuous subcutaneous insulin infusion (CSII) (#161)
9:30 AM
Earlier onset of exposure and greater early pharmacokinetic and pharmacodynamic effects for faster-acting insulin aspart vs. insulin aspart using continuous subcutaneous insulin infusion (#162)
9:45 AM
Psychometric Validation of the Novel Glucose Monitoring Experiences Questionnaire (GME-Q) among Adults with Type 1 Diabetes (#163)
10:00 AM
Assessing the impact of insulin pump therapy on behaviour, mood, cognition and glycaemia in youth with Type 1 Diabetes – a randomised controlled trial (#164)
10:15 AM
Faster-acting insulin aspart demonstrates higher early insulin exposure and greater early glucose-lowering effect vs. insulin aspart across a clinically relevant dose range (#165)
10:30 AM
Regulation of alpha cell function and fatty acid levels by hyperinsulinaemia after islet cell transplantation in Type 1 diabetes (#166)
10:45 AM